20 Most Valuable Healthcare Companies in the World

Published on November 20, 2023 at 6:52 am by Meerub Anjum in Business, Industries, Lists, News

In this article, we will look into the 20 most valuable healthcare companies in the world. If you want to skip our detailed analysis, you can go directly to the 5 Most Valuable Healthcare Companies in the World.

Healthcare Services Industry: A Market Analysis

According to a report by Verified Market Research, the global healthcare services market was worth $10.30 trillion in 2021. The market is expected to grow at a CAGR of 8.27% and reach $21.6 trillion by 2030. The healthcare industry has grown considerably over the past few decades. The growth is characterized by technological advancement in disease detection, testing, research, and treatment. The market is expected to benefit from rising awareness about healthcare, increased profitability, rising economic growth, and a high demand from the aging population. The major trends in the healthcare services market include the adoption of digital tools, increased cross-company and cross-industry partnerships, innovative and novel drug development, a growing trend of bundled payments, and hybrid imaging techniques among others.

The market is segmented into hospitals and clinics, dental services, nursing care, laboratory services, and pharmaceutical companies including others, by type. It is expected to be dominated by the hospital segment over the forecasted period, due to hospitals being the major earning source in the industry.

Regionally, North America dominated the market and generated the maximum revenue share in 2021. Asia Pacific is expected to experience significant growth over the forecasted period. The growth is driven by increased private investment in the healthcare industry in countries like China, India, and Thailand among others.

Healthcare Market in the US

According to a report by McKinsey and Company, the market will face challenges like inflation and a shortage of workers in 2023 but is expected to rebound in 2024. The US healthcare revenue was $654 billion in 2021. The revenue is expected to grow and reach $790 billion in 2026. The fastest growing segment in the region is projected to be healthcare services and technology, with a CAGR of 10% followed by specialty pharmacy, with a CAGR of 7% over the forecasted period. The government investment segment is expected to grow, with medical advantage penetration estimated to reach 52% in 2026.

Key Players in the Industry

Some of the major companies leading the healthcare market include Eli Lilly and Company (NYSE:LLY), UnitedHealth Group Incorporated (NYSE:UNH), and Johnson & Johnson (NYSE:JNJ).

Eli Lilly and Company (NYSE:LLY) is a global leader in the healthcare industry. On November 2, Eli Lilly and Company (NYSE:LLY) reported its earnings for the fiscal third quarter. The company reported a revenue of $9.50 billion and outperformed revenue consensus by $508.16 million. The company’s revenue for the quarter grew 36.84% on a year-over-year basis.

Here are some of the comments from Eli Lilly and Company’s (NYSE:LLY) Q3 2023 earnings:

“Our new products and growth products combined contributed approximately 17 percentage points toward volume growth, with over 12 percentage points coming from our growth products. Last week, we announced that the FDA approved Omvoh for the treatment of moderately to severely active ulcerative colitis in adults.

This marks Lilly’s first approval in the U.S. for a type of inflammatory bowel disease. And it’s important for Lilly’s growth in its immunology portfolio. In addition to the FDA approval for Omvoh, we had several other important pipeline updates since our last earnings call. Specifically Jardiance was approved by the FDA for the treatment of adults with chronic kidney disease, at risk of progression. And we reported positive Phase 3 results from the VIVID-1 trial which evaluated the safety and efficacy of mirikizumab for the treatment of adults with moderately to severely active Crohn’s disease. In Q3, we announced that the FDA issued a Complete Response Letter for lebrikizumab based on inspection findings at a third party manufacturer. The letter stated no concerns with the clinical data package, the safety or the label.

We will continue to work with the third party manufacturer and the FDA to address the findings to make lebrikizumab available to patients as quickly as possible. In terms of business development, we once again had a very active quarter. In Q3, we completed the divestiture of the olanzapine portfolio, which will further enable us to focus on our current and new product launches. The financial impact of this transaction is reflected in the Q3 results. Additionally, within the quarter, we completed the acquisition of two clinical stage companies, adding to our Phase 2 portfolio, DICE Therapeutics and Versanis Bio as well as the acquisition of Emergence Therapeutics and Sigilon Therapeutics. We also announced that we reached an agreement to acquire POINT Biopharma, which, if approved, has the potential to expand our oncology capabilities into next generation radioligand therapies. And lastly, we distributed over a $1 billion in dividends this quarter.”

UnitedHealth Group Incorporated (NYSE:UNH) is a leading healthcare and insurance company. On November 2, the company announced its partnership with the Hispanic Federation (HF), a nonprofit organization, with the mission of empowering the Latino community. The partnership is a three-year collaboration granting $3 million in funding, to support the Hispanic Federation’s (HF) attempts to reduce the discrepancies around diabetes in the Latino community. Latino community reports an over 50% chance of developing type 2 diabetes over a lifetime. The grant will fund a program in Atlanta, Dallas, and Houston for Latino individuals. The program will provide related resources to promote the adoption and maintenance of healthy habits and physical activity. It will also provide individuals with primary and mental health care, health screenings, and access to healthy food. This grant is a result of the success of the company’s five-year pilot program in Florida, which enabled the participants to reduce their body weight by an average of 6.8% over six months.

Johnson & Johnson (NYSE:JNJ) is a leading healthcare company, specializing in pharmaceutical and medical technology. On November 1, Johnson & Johnson’s (NYSE:JNJ) subsidiary, Johnson & Johnson Innovation (JLABS), announced its collaboration with the Singapore Economic Development Board. The partnership is set to launch the Singapore QuickFire Challenge (QFC), a challenge for innovators to provide healthcare solutions. The challenge, QFC, will grant funding of $100,000 to the innovators with the best solutions. JLabs will also be helping the healthcare companies in Singapore, that are in their initial development stages. The company will support them by providing the resources and mentorship required to expand their innovative medicines, medical technologies, and healthcare solutions.

Now that we have talked about the market trends in the healthcare industry and discussed the major players, let’s have a look at the 20 most valuable healthcare companies in the world.

20 Most Valuable Healthcare Companies in the World

Methodology

To rank the 20 most valuable healthcare companies in the world, we screened the companies listed under healthcare using stock screeners from Finviz and Yahoo Finance. We also researched healthcare companies by reviewing market reports. Then, we narrowed down our selection to 20 companies that are the biggest by market cap, as of November 5, and ranked them in ascending order of this metric.

20 Most Valuable Healthcare Companies in the World

20. Medtronic plc (NYSE:MDT)

Market Cap as of November 5: $96.54 billion

Medtronic plc (NYSE:MDT) is ranked among the most valuable healthcare companies in the world. Medtronic plc (NYSE:MDT) provides innovative products and services, utilizing the latest medical technology. Medtronic plc (NYSE:MDT) has headquarters and principal executive offices in Dublin, Ireland. As of November 5, Medtronic plc (NYSE:MDT) has a market cap of $96.54 billion.

Eli Lilly and Company (NYSE:LLY), UnitedHealth Group Incorporated (NYSE:UNH), and Johnson & Johnson (NYSE:JNJ) are some of the major companies leading the healthcare market.

19. Gilead Sciences, Inc. (NASDAQ:GILD)

Market Cap as of November 5: $101.66 billion

Gilead Sciences, Inc. (NASDAQ:GILD) is an American healthcare company, specializing in biopharmaceutical solutions. Gilead Sciences, Inc. (NASDAQ:GILD) is leading the market with the discovery, development, and commercialization of innovative medicines. As of November 5, Gilead Sciences, Inc. (NASDAQ:GILD) has a market cap of $101.66 billion.

18. Stryker Corporation (NYSE:SYK)

Market Cap as of November 5: $104.94 billion

Stryker Corporation (NYSE:SYK) is an American healthcare company, specializing in medical devices and equipment manufacturing. Stryker Corporation (NYSE:SYK) is leading the market with innovative orthopedics, medical, surgical, and neurotechnology solutions. As of November 5, Stryker Corporation (NYSE:SYK) has a market cap of $104.94 billion.

17. Elevance Health, Inc. (NYSE:ELV)

Market Cap as of November 5: $106.08 billion

Elevance Health, Inc. (NYSE:ELV) is a top American health insurance company leading the market with its integrated healthcare solutions. Elevance Health, Inc. (NYSE:ELV) serves more than 118 million people, at every stage providing them with medical, digital, behavioral, clinical, and complex care solutions. As of November 5, Elevance Health, Inc. (NYSE:ELV) has a market cap of $106.08 billion.

16. Bristol-Myers Squibb Company (NYSE:BMY)

Market Cap as of November 5: $107.47 billion

Bristol-Myers Squibb Company (NYSE:BMY) is ranked among the most valuable healthcare companies in the world, known for its biological and pharmaceutical research. As of November 5, Bristol-Myers Squibb Company (NYSE:BMY) boasts a market cap of $107.47 billion.

15. Sanofi (NASDAQ:SNY)

Market Cap as of November 5: $115.75 billion

Sanofi (NASDAQ:SNY) is a leading French healthcare company, headquartered in Paris. Sanofi (NASDAQ:SNY) specializes in the development and production of innovative medicines and healthcare solutions. As of November 5, Sanofi (NASDAQ:SNY) has a market cap of $115.75 billion.

14. Amgen Inc. (NASDAQ:AMGN)

Market Cap as of November 5: $144.42 billion

Amgen Inc. (NASDAQ:AMGN) is one of the most valuable healthcare companies, leading the market with innovative biotech solutions. Amgen Inc. (NASDAQ:AMGN) is a pioneer in developing biological medicines using living cells. As of November 5, Amgen Inc. (NASDAQ:AMGN) boasts a market cap of $144.42 billion.

13. Danaher Corporation (NYSE:DHR)

Market Cap as of November 5: $146.21 billion

Danaher Corporation (NYSE:DHR) is a leading manufacturer and developer of medical products, headquartered in Washington D.C. Danaher Corporation (NYSE:DHR) is ranked 13th on our list with a market cap of $146.21 billion.

12. Abbott Laboratories (NYSE:ABT)

Market Cap as of November 5: $166.59 billion

Abbott Laboratories (NYSE:ABT) is a top American healthcare company, that specializes in innovative medical devices and healthcare solutions. As of November 5, Abbott Laboratories (NYSE:ABT) has a market cap of $166.59 billion.

11. Thermo Fisher Scientific Inc. (NYSE:TMO)

Market Cap as of November 5: $175.70 billion

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the most valuable healthcare companies, leading the market with innovative biotech solutions. Thermo Fisher Scientific Inc. (NYSE:TMO) is a global supplier of analytical instruments, biotechnology services, and specialty diagnostics. As of November 5, Thermo Fisher Scientific Inc. (NYSE:TMO) boasts a market cap of $175.70 billion.

10. Pfizer Inc. (NYSE:PFE)

Market Cap as of November 5: $176.49 billion

Pfizer Inc. (NYSE:PFE) is a leading American healthcare company, specializing in innovative pharmaceutical and biotech solutions. As of November 5, Pfizer Inc. (NYSE:PFE) has a market cap of $176.49 billion.

9. Novartis AG (NYSE:NVS)

Market Cap as of November 5: $190.66 billion

Novartis AG (NYSE:NVS) is one of the most valuable healthcare companies, leading the market with innovative pharmaceutical solutions. Novartis AG (NYSE:NVS) was founded in 1996 in Basel, Switzerland. It is a global leader in the research, development, and manufacturing of medicines. As of November 5, Novartis AG (NYSE:NVS) boasts a market cap of $190.66 billion.

8. AstraZeneca PLC (NASDAQ:AZN)

Market Cap as of November 5: $198.27 billion

AstraZeneca PLC (NASDAQ:AZN) is ranked 8th on our list of the most valuable healthcare companies in the world. The Anglo-Swedish multinational company is leading the market with its innovative biotech and pharmaceutical solutions. The company is headquartered in Cambridge, UK, and has offices all over the world. As of November 5, AstraZeneca PLC (NASDAQ:AZN) has a market cap of $198.27 billion.

7. Roche Holding AG (OTC:RHHBY)

Market Cap as of November 5: $211.87 billion

Roche Holding AG (OTC:RHHBY) is a leading Swiss healthcare company, headquartered in Basel, Switzerland. Roche Holding AG (OTC:RHHBY) specializes in pharmaceuticals and diagnostics. As of November 5, Roche Holding AG (OTC:RHHBY) has a market cap of $211.87 billion.

6. AbbVie Inc. (NYSE:ABBV)

Market Cap as of November 5: $249.61 billion

AbbVie Inc. (NYSE:ABBV) is a leading American healthcare company, headquartered in Chicago, Illinois. AbbVie Inc. (NYSE:ABBV) specializes in innovative medicines and healthcare solutions. As of November 5, AbbVie Inc. (NYSE:ABBV) has a market cap of $249.61 billion.

The healthcare market is expected to experience significant growth. Investors can increase their exposure to the market by investing in stocks including Eli Lilly and Company (NYSE:LLY), UnitedHealth Group Incorporated (NYSE:UNH), and Johnson & Johnson (NYSE:JNJ).

Click to continue reading and see 5 Most Valuable Healthcare Companies in the World.

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Published on June 23, 2025 at by Inan Dogan, PhD

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

AI is eating the world—and the machines behind it are ravenous.

Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy. In fact, AI is already pushing global power grids to the brink.

Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and building the digital future. But there’s one urgent question few are asking:

Where will all of that energy come from?

AI is the most electricity-hungry technology ever invented. Each data center powering large language models like ChatGPT consumes as much energy as a small city. And it’s about to get worse.

Even Sam Altman, the founder of OpenAI, issued a stark warning:

“The future of AI depends on an energy breakthrough.”

Elon Musk was even more blunt:

“AI will run out of electricity by next year.”

As the world chases faster, smarter machines, a hidden crisis is emerging behind the scenes. Power grids are strained. Electricity prices are rising. Utilities are scrambling to expand capacity.

And that’s where the real opportunity lies…

One little-known company—almost entirely overlooked by most AI investors—could be the ultimate backdoor play. It’s not a chipmaker. It’s not a cloud platform. But it might be the most important AI stock in the US owns critical energy infrastructure assets positioned to feed the coming AI energy spike.

As demand from AI data centers explodes, this company is gearing up to profit from the most valuable commodity in the digital age: electricity.

The “Toll Booth” Operator of the AI Energy Boom

It owns critical nuclear energy infrastructure assets, positioning it at the heart of America’s next-generation power strategy.
It’s one of the only global companies capable of executing large-scale, complex EPC (engineering, procurement, and construction) projects across oil, gas, renewable fuels, and industrial infrastructure.
It plays a pivotal role in U.S. LNG exportation—a sector about to explode under President Trump’s renewed “America First” energy doctrine.

Trump has made it clear: Europe and U.S. allies must buy American LNG.

And our company sits in the toll booth—collecting fees on every drop exported.

But that’s not all…

As Trump’s proposed tariffs push American manufacturers to bring their operations back home, this company will be first in line to rebuild, retrofit, and reengineer those facilities.

AI. Energy. Tariffs. Onshoring. This One Company Ties It All Together.

While the world is distracted by flashy AI tickers, a few smart investors are quietly scooping up shares of the one company powering it all from behind the scenes.

AI needs energy. Energy needs infrastructure.

And infrastructure needs a builder with experience, scale, and execution.

This company has its finger in every pie—and Wall Street is just starting to notice.

Wall Street is noticing this company also because it is quietly riding all of these tailwinds—without the sky-high valuation.

While most energy and utility firms are buried under mountains of debt and coughing up hefty interest payments just to appease bondholders…

This company is completely debt-free.

In fact, it’s sitting on a war chest of cash—equal to nearly one-third of its entire market cap.

It also owns a huge equity stake in another red-hot AI play, giving investors indirect exposure to multiple AI growth engines without paying a premium.

And here’s what the smart money has started whispering…

The Hedge Fund Secret That’s Starting to Leak Out

This stock is so off-the-radar, so absurdly undervalued, that some of the most secretive hedge fund managers in the world have begun pitching it at closed-door investment summits.

They’re sharing it quietly, away from the cameras, to rooms full of ultra-wealthy clients.

Why? Because excluding cash and investments, this company is trading at less than 7 times earnings.

And that’s for a business tied to:

The AI infrastructure supercycle
The onshoring boom driven by Trump-era tariffs
A surge in U.S. LNG exports
And a unique footprint in nuclear energy—the future of clean, reliable power

You simply won’t find another AI and energy stock this cheap… with this much upside.

This isn’t a hype stock. It’s not riding on hope.

It’s delivering real cash flows, owns critical infrastructure, and holds stakes in other major growth stories.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 100+% Return within 12 to 24 months.

We’re now offering month-to-month subscriptions with no commitments.

For a ridiculously low price of just $9.99 per month, you can unlock our in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

Access to our Detailed Report on our AI, Tariffs, and Nuclear Energy Stock with 100+% potential upside within 12 to 24 months
BONUS REPORT on our #1 AI-Robotics Stock with 10000% upside potential: Our in-depth report dives deep into our #1 AI/robotics stock’s groundbreaking technology and massive growth potential.
One New Issue of Our Premium Readership Newsletter: You will also receive one new issue per month and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.
One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149
Bonus Content: Premium access to members-only fund manager video interviews
Ad-Free Browsing: Enjoy a month of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.
Lifetime Price Guarantee: Your renewal rate will always remain the same as long as your subscription is active.
30-Day Money-Back Guarantee: If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Subscribe Now!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!

Insider Monkey Ads

A New Dawn is Coming to U.S. Stocks

Published on June 13, 2025 at by Insider Monkey Staff

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…

Insider Monkey Ads

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Log In

Sign Up

20 Most Valuable Healthcare Companies in the World

Published on November 20, 2023 at 6:52 am by Meerub Anjum in Business, Industries, Lists, News

Healthcare Services Industry: A Market Analysis

Healthcare Market in the US

Key Players in the Industry

20 Most Valuable Healthcare Companies in the World

20. Medtronic plc (NYSE:MDT)

19. Gilead Sciences, Inc. (NASDAQ:GILD)

18. Stryker Corporation (NYSE:SYK)

17. Elevance Health, Inc. (NYSE:ELV)

16. Bristol-Myers Squibb Company (NYSE:BMY)

15. Sanofi (NASDAQ:SNY)

14. Amgen Inc. (NASDAQ:AMGN)

13. Danaher Corporation (NYSE:DHR)

12. Abbott Laboratories (NYSE:ABT)

11. Thermo Fisher Scientific Inc. (NYSE:TMO)

10. Pfizer Inc. (NYSE:PFE)

9. Novartis AG (NYSE:NVS)

8. AstraZeneca PLC (NASDAQ:AZN)

7. Roche Holding AG (OTC:RHHBY)

6. AbbVie Inc. (NYSE:ABBV)

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Published on June 23, 2025 at by Inan Dogan, PhD

Here’s why this is a deal you can’t afford to pass up:

A New Dawn is Coming to U.S. Stocks

Published on June 13, 2025 at by Insider Monkey Staff

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Premium

Log In

Sign Up

20 Most Valuable Healthcare Companies in the World

Published on November 20, 2023 at 6:52 am by Meerub Anjum in Business, Industries, Lists, News

Share

Healthcare Services Industry: A Market Analysis

Healthcare Market in the US

Key Players in the Industry

20 Most Valuable Healthcare Companies in the World

20. Medtronic plc (NYSE:MDT)

19. Gilead Sciences, Inc. (NASDAQ:GILD)

18. Stryker Corporation (NYSE:SYK)

17. Elevance Health, Inc. (NYSE:ELV)

16. Bristol-Myers Squibb Company (NYSE:BMY)

15. Sanofi (NASDAQ:SNY)

14. Amgen Inc. (NASDAQ:AMGN)

13. Danaher Corporation (NYSE:DHR)

12. Abbott Laboratories (NYSE:ABT)

11. Thermo Fisher Scientific Inc. (NYSE:TMO)

10. Pfizer Inc. (NYSE:PFE)

9. Novartis AG (NYSE:NVS)

8. AstraZeneca PLC (NASDAQ:AZN)

7. Roche Holding AG (OTC:RHHBY)

6. AbbVie Inc. (NYSE:ABBV)

Share

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Published on June 23, 2025 at by Inan Dogan, PhD

Here’s why this is a deal you can’t afford to pass up:

A New Dawn is Coming to U.S. Stocks

Published on June 13, 2025 at by Insider Monkey Staff